Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Essen Biotech
Incyte Corporation
Incyte Corporation
Novartis
RAPT Therapeutics, Inc.
ModernaTX, Inc.
City of Hope Medical Center
Incyte Corporation
Shenzhen BinDeBio Ltd.
Amgen
University of Kentucky
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center